Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 4/20 | 0.54 |
| ▸ | NPY1R | P25929 | 3/20 | 0.54 |
| ▸ | NPY2R | P49146 | 3/20 | 0.54 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.53 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.52 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.52 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL266554 | 1.00 | NPY4R (0.54) | NPY4RNPY1RNPY2RENPEPERAP2 | |
| SCHEMBL30252225 | 1.00 | NPY4R (0.54) | NPY4RNPY1RNPY2RENPEPERAP2 | |
| SCHEMBL29948864 | 1.00 | NPY4R (0.54) | NPY4RNPY1RNPY2RENPEPERAP2 | |
| SCHEMBL266555 | 1.00 | NPY4R (0.54) | NPY4RNPY1RNPY2RENPEPERAP2 | |
| SCHEMBL4293347 | 1.00 | NPY4R (0.54) | NPY4RNPY1RNPY2RENPEPERAP2 | |
| SCHEMBL29365741 | 1.00 | NPY4R (0.54) | NPY4RNPY1RNPY2RENPEPERAP2 | |
| SCHEMBL4420809 | 0.98 | ENPEP (0.56) | NPY4RNPY1RNPY2RENPEPERAP2 | |
| SCHEMBL5032917 | 0.97 | ENPEP (0.56) | NPY4RNPY1RNPY2RENPEPERAP2 | |
| SCHEMBL31467474 | 0.97 | ERAP2 (0.55) | NPY4RNPY1RNPY2RENPEPERAP2 | |
| SCHEMBL27906634 | 0.94 | ENPEP (0.52) | NPY4RNPY1RNPY2RENPEPERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080209-A | Anti-CTLA-4 binding proteins and methods of use thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-119930820-A | Anti-CTLA-4 binding proteins and methods of use thereof | 吉加根公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-114008071-B | Anti-CTLA-4 binding proteins and methods of use thereof | 吉加根公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-110997922-B | Cell-free protein expression using double-stranded concatemer DNA | 环球生命科学解决方案运营英国有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20240050460-A1 | Pharmaceuticals That Promote Functional Regeneration of Damaged Tissues | StemRIM Inc. (JP) | 2024-02-15 | — | — | US | disclosed |
| CN-116234821-A | anti-CTLA-4 binding proteins and methods of use thereof | 吉加根公司 | 2023-06-06 | — | — | CN | disclosed |
| US-20090291086-A1 | Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia | ALAVITA PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | US | disclosed |